Evaluation of the effect of a herbal mixture on non alcoholic fatty liver disease

Not Applicable

• Conditions: on alcoholic fatty liver desease.; Fatty (change of) liver, not elsewhere classified; K76.0

• Registration Number: IRCT2015123025772N1
• Lead Sponsor: Vice chancellor for Research, Mashhad University of Medical Science

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 September 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 64

Inclusion Criteria

patients with nonalcoholic fatty liver disease with grade = 2 of steatosis on sonography or grade 1 of steatosis + elevated serum alanine transaminase level

Exclusion Criteria

Having special or chronic disease like auto immune diseases, hypothyroidism, lupus, renal dysfunction, cancers, heart diseases, and severe infections
Cirrhosis or Hepatitis B and C
Pregnancy and lactation
Unwillingness to continue treatment with herbal compound

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Alanine transaminase (ALT). Timepoint: Before intervention, two month after intervention. Method of measurement: Blood examination.;Steatosis of liver. Timepoint: Before intervention, two month after intervention. Method of measurement: Sonography.

Secondary Outcome Measures

Name	Time	Method
Aspartate transaminase (AST). Timepoint: Before starting study and 2 months after starting study. Method of measurement: Blood analysis (kit).;Fasting blood glucose. Timepoint: Before starting study and 2 months after starting study. Method of measurement: Blood analysis (kit).;Serum lipids. Timepoint: Before starting study and 2 months after starting study. Method of measurement: Blood analysis (kit) for total cholesterol and triglyceride.